One of thee top-rated benefits DIA member receive, TIRS advances health care product discovery development,regulation, and use through the publication of peer-reviewed articles and commentaries across the spectrum of converting biomedical science into practical solutions to advance human health.
Gregory Daniel
Editor-in-Chief
Gregory Daniel, PhD, MPH is the Deputy Director of the Duke-Robert J. Margolis, MD Center for Health Policy and a Clinical Professor in Duke's Fuqua School of Business. He directs the DC-based office of the Center leading its pharmaceutical and medical device policy portfolio, and is also an Adjunct Associate Professor at the UNC Eshelman School of Pharmacy. Dr. Daniel’s research expertise includes RWE development utilizing electronic health data in the areas of health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology. He received a PhD in pharmaceutical economics, policy and outcomes from the University of Arizona, and an MPH, MS, and BS in Pharmacy all from The Ohio State University.
Editorial Board
-
Theresa Allio
Advanced Accelerator Applications -
Dr. Christopher P. Austin
Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH) -
Josephine Babiarz
Associate Professor , MCPHS University -
Paul A. Bleicher
Chief Executive Officer , OptumLabs -
Leona Blustein
Regional Medical Advisor, Arena Pharmaceuticals -
David R. Bristol
President, Statistical Consulting Services, Inc. -
Joseph Cappelleri
Executive Director of Biostatistics, Pfizer Inc -
Andrzej Czarnecki
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety, Eli Lilly and Company -
Richard O. Day
Associate Editor
Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital -
Dr. Lode Dewulf
Chief Patient Officer, Servier Monde -
Joseph A DiMasi
Director, Economic Analysis and Research Associate Professor , Tufts Center for the Study of Drug Development -
Rafe Donahue
Senior Director, Statistics, Wright Medical -
Sara Doshi
Director, Medical Information Strategy and Capabilities, GMI, Eli Lilly and Company -
Todd Durham
Durham Statistical Consulting LLC -
Ron Fitzmartin
Senior Informatics Advisor, Office of the Director, CBER, FDA -
Erick Gaussens
ProductLife Group -
Barbara Gladson
Director of Biopharma Initiative; Interim Chair, Health Informatics, Rutgers School of Health Professions -
Alan M. Hochberg
Scientific Enablement Leader, F. Hoffmann-La Roche Ltd. -
Stuart Horowitz
President, Institutions & Institutional Services, WCG -
Lisa Kammerman
Associate Editor
Regulatory Statistics and PRO Consultant, Kammerman Consulting, LLC -
Mitchell W. Krucoff
Professor of Medicine/Cardiology, Duke University -
Gracie Lieberman
Associate Editor
Director Regulatory Policy, Genentech, A Member of the Roche Group -
Craig Lipset
Former Head of Clinical Innovation, Pfizer -
Wendy Louise Lipworth
Senior Research Fellow, Centre for Values, Ethics and the Law in Medicine, University of Sydney -
Christopher Paul Milne
Director of Research and Research Associate Professor, Tufts Center for the Study of Drug Development -
Shunsuke Ono
Associate Professor, Laboratory of Pharmaceutical Regulatory Science, The University of Tokyo -
Minsoo Park
KCGI -
Monika M. Pietrek
Managing Director and Senior Consultant, Pietrek Associates GmbH -
Peter J. Pitts
President, Center for Medicine in the Public Interest -
Ronald Portman
Executive Director, Pediatric Therapeutic Area , Novartis Pharmaceuticals Corporation -
Daniel S Reshef
Safety Science Leader, Hoffman-La Roche, Inc. -
Anne Rowzee
Associate Editor
Science Policy Analyst, FDA -
Ramses F Sadek
Professor of Biostatistics & Director of CRC BiostatisticsCore, Georgia Cancer Center at Augusta University -
Jonathan Seltzer
President and Chief Executive Officer, ACI Clinical -
Mitchell Seymour
Principal/Founder; Lead, Regulatory Operations, R&D Advisors, LLC; University of Michigan -
R.William Soller
President, Biomedical Regulatory Consulting -
Amy Sun
Senior Director, Sanofi-Aventis -
Tetsuya Tanimoto
Reviewer, Office of Biologics I, Pharmaceuticals and Medical Devices Agency (PMDA) -
Rick Turner
Editor Emeritus
Expert Consultant, DRT Strategies, Inc. -
Richard Zink
Associate Editor
Senior Director, Data Management and Statistics, TARGET Pharmasolutions Inc
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!